ArticleCancer management and research2018

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.

Satoshi Igawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.